Old Web
English
Sign In
Acemap
>
authorDetail
>
Jane E. Huang
Jane E. Huang
University of North Carolina at Chapel Hill
Bevacizumab
Medicine
Carboplatin
Phases of clinical research
Lung cancer
4
Papers
392
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Randomized Phase II Study of Bevacizumab in Combination With Chemotherapy in Previously Untreated Extensive-Stage Small-Cell Lung Cancer: Results From the SALUTE Trial
2011
Journal of Clinical Oncology
David R. Spigel
Peter M. Townley
David Waterhouse
Liang Fang
Ibrahim Adiguzel
Jane E. Huang
David A. Karlin
Leonardo Faoro
Frank A. Scappaticci
Mark A. Socinski
Show All
Source
Cite
Save
Citations (142)
BRIDGE: An open-label phase II trial evaluating the safety of bevacizumab (BV) plus paclitaxel/carboplatin (PC) as first-line treatment (tx) for patients (pts) with advanced, previously untreated, squamous non-small cell lung cancer (NSCLC).
2010
Journal of Clinical Oncology
Leonardo Faoro
John D. Hainsworth
David A. Karlin
Jane E. Huang
Liang Fang
Frank A. Scappaticci
Show All
Source
Cite
Save
Citations (9)
Safety of Bevacizumab in Patients With Non–Small-Cell Lung Cancer and Brain Metastases
2009
Journal of Clinical Oncology
Mark A. Socinski
Corey J. Langer
Jane E. Huang
Margaret M. Kolb
Peter Compton
Lisa Wang
Wallace Akerley
Show All
Source
Cite
Save
Citations (208)
Acceptable safety of bevacizumab therapy in patients with brain metastases due to non-small cell lung cancer
2008
Journal of Clinical Oncology
Wallace Akerley
Corey J. Langer
Y. Oh
D.K. Strickland
S. Joo Royer
Q. Xia
Y. Mu
Jane E. Huang
Mark A. Socinski
Show All
Source
Cite
Save
Citations (33)
1